FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080395 [Registered on: 12/02/2025] Trial Registered Prospectively
Last Modified On: 30/01/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Non-randomized, Active Controlled Trial 
Public Title of Study   A role of saraswat Ghrita and Chaturbhadra Kalpa Basti in the management of delayed milestones in Children  
Scientific Title of Study   An Open labelled Non Randomised Parallel group clinical controlled trial on Saraswata Ghrita ( oral) and Chaturbhadra Kalpa Basti in the management of Global developmental delay (GDD) in Children  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mamta Chandra  
Designation  MD Scholar  
Affiliation  State Ayurvedic college and hospital lucknow  
Address  P.G. Dept. of Kaumarabhritya OPD NO.1 , State Ayurvedic college and hospital ,lucknow Lucknow UTTAR PRADESH 226003

Lucknow
UTTAR PRADESH
226003
India 
Phone  7985994287  
Fax    
Email  mamtachandra14794@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Laxmi  
Designation  Asst. Professor  
Affiliation  State Ayurvedic college and hospital lucknow  
Address  P.G. Dept. of Kaumarabhritya OPD NO.1 , State Ayurvedic college and hospital ,lucknow Lucknow UTTAR PRADESH 226003 India

Lucknow
UTTAR PRADESH
226003
India 
Phone  9792446688  
Fax    
Email  lakshmiomsingh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Laxmi  
Designation  Asst. Professor  
Affiliation  State Ayurvedic college and hospital lucknow  
Address  P.G. Dept. of Kaumarabhritya OPD NO.1 , State Ayurvedic college and hospital ,lucknow Lucknow UTTAR PRADESH 226003 India

Lucknow
UTTAR PRADESH
226003
India 
Phone  9792446688  
Fax    
Email  lakshmiomsingh@gmail.com  
 
Source of Monetary or Material Support  
State Ayurvedic College and hospital,Turiyaganj, tulsidas Marg, Lucknow, Uttar Pradesh Pincode 226003 
 
Primary Sponsor  
Name  State Ayurvedic college and hospital lucknow  
Address  Tulsidas Marg ,old Haidar, Lucknow 226003 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mamta Chandra   State Ayurvedic college and hospital Lucknow   Department of Kaumarabhritya OPD No.1, State Ayurvedic college and hospital Tulsidas Marg, lucknow UTTAR PRADESH
Lucknow
UTTAR PRADESH 
7985994287

mamtachandra14794@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Office of Institutional Ethics committee, State Ayurvedic College and hospital lucknow, lucknow   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F59||Unspecified behavioral syndromes associated with physiological disturbances and physical factors. Ayurveda Condition: BALA-PAKSHAGHATAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Saraswata Ghrita , Reference: Bhava Prakash Madhayam khand 24/46,47, Route: Oral, Dosage Form: Ghrita, Dose: 10(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 84 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmProcedure-Chaturbhadra Kalp Basti (Procedure Reference: Kashyap Khila asthana 8/23-24, Procedure details: There is use of 4 sneha Basti in beginning , 4 niruha basti in mid, 4 sneha basti 12 day as per schedule )
(1) Medicine Name: Saraswata Ghrita , Madhu tailik , Reference: Bhava prakash madhayam khand 24/46 , sushrut chikitsa 38/100-101, Route: Rectal, Dosage Form: Ghrita, Dose: 100(ml), Frequency: od, Duration: 12 Days
 
Inclusion Criteria  
Age From  1.00 Year(s)
Age To  5.00 Year(s)
Gender  Both 
Details  1. Child between age Group of 1-5 yr of either sex are diagnosed GDD
2 .Child / parents willing to participate in the Trial.
3. Children with developmentaldisabilities of both physical and mental ( delayed
milestone)
4. Unable to stand , walk, speech, sitting as per age.
5. Child with altered IQ as per age.
6. Child with altered social & behaviour as per age 
 
ExclusionCriteria 
Details  1.Child of age less then 1 year. and more then 5 years.
2.Child with sever infection, systemic illness like TB. Gastrointestinal disease
3.Child with genetic disorder like down syndrome or any congenital anomalies
4.Child suffering from any muscular dystrophy (DMD)
5.Child having abnormal CT/MRI brain finding with abnormal EEG finding
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1. Improvement in quality of life in children .

2. Improvement in speech/language/Communication/sociability/sensory/cognitive awareness , locomotary disability. 
After 84th day of trial  
 
Secondary Outcome  
Outcome  TimePoints 
•To Check the efficacy of Saraswata ghrita in the case of GDD.
•To evaluate the role of Chaturbhadra kalp basti in GDD. 
1st,36th,72th,84th day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   20/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="24" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Global Developmental delay ( GDD ) is one of the most steadily rising complex neuromuscular developmental disorder in past few decades, but there is no certain treatment available in any modalities. Ayurveda is the ray of hope for such kind of  clinical conditions.Therefore, I select this trial. Clinical trial will be done on two group A and B . In group A Saraswata ghrita using route of administration as Paan (Oral route) for 84 day’s without any gap and In Group B Chaturbhadra Kalp Basti (Per rectal route) ,12 day schedule ( 4 sneha vasti in beginning, 4 niruh vasti in mid, 4 sneha vasti in last ). Minimum 30 GDD  diagnosed children, aged 1 to 5 years clinically studies of treatment modules. Each segment of treatment module will be  for 84 day’s. After, each treatment there is a gap of 24  days in group  B, Total duration of trial is 84 days. A follow up will be done after 30 days of complete clinical trial. 
Close